Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry

Summary. High frequencies of the C282Y and H63D mutations of the HFE gene occur in European populations, even though homozygous and compound heterozygous states are associated with hereditary haemochromatosis, which is a disease that decreases fitness. This suggests that heterozygotes may possess a selective advantage. HFE mutations increase iron absorption in patients with haemochromatosis, and the mean transferrin saturations and ferritin levels are mildly increased in heterozygotes, suggesting that HFE mutations may protect against iron depletion and iron deficiency anaemia. In this study of 23 681 Caucasian adults, mean transferrin saturation, serum ferritin and haemoglobin levels were significantly higher in subjects carrying HFE mutations compared with wild types. Analysed by ethnicity, mean haemoglobin and mean erythrocyte volume (MCV) were significantly lower in those with a southern versus northern European ancestry. C282Y mutation carriers had an increased mean haemoglobin level in both ethnic groups. Prevalence of non‐anaemic iron deficiency was significantly lower among female carriers of the C282Y mutation compared with HFE wild types. However, prevalence of frank iron deficiency anaemia did not differ significantly among genotypes. Quantile:quantile plots showed a small but significant upward shift in the mid‐range of the haemoglobin distribution among C282Y mutation carriers that was consistent with an increased mean haemoglobin level without significant changes in the anaemic range.

[1]  J. Koziol,et al.  Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA , 2002, The Lancet.

[2]  M. Worwood,et al.  HFE mutations, iron deficiency and overload in 10 500 blood donors , 2001, British journal of haematology.

[3]  P. Bärtsch,et al.  Effects of iron repletion on blood volume and performance capacity in young athletes. , 2001, Medicine and science in sports and exercise.

[4]  M. Bulsara,et al.  Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. , 2001, Clinical Chemistry.

[5]  C. Enns,et al.  Iron homeostasis: new tales from the crypt. , 2000, Blood.

[6]  V. Felitti,et al.  The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic , 2000, Annals of Internal Medicine.

[7]  M. Bulsara,et al.  Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. , 2000, Clinical chemistry.

[8]  Jennifer J. Pointon,et al.  Geography of HFE C282Y and H63D mutations. , 2000, Genetic testing.

[9]  E. Beutler,et al.  Large-scale screening for HFE mutations: methodology and cost. , 2000, Genetic testing.

[10]  C. Datz,et al.  Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? , 1998, Clinical chemistry.

[11]  H Clevers,et al.  Adaptive response of iron absorption to anemia, increased erythropoiesis, iron deficiency, and iron loading in beta2-microglobulin knockout mice. , 1998, Blood.

[12]  M. Carroll,et al.  Prevalence of iron deficiency in the United States. , 1997, JAMA.

[13]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[14]  Motulsky Ag Genetics of hemochromatosis. , 1979 .

[15]  M. Simon Genetics of hemochromatosis. , 1979, The New England journal of medicine.

[16]  R. Gnanadesikan,et al.  Probability plotting methods for the analysis of data. , 1968, Biometrika.

[17]  E. Beutler,et al.  Iron therapy in chronically fatigued, nonanemic women: a double-blind study. , 1960, Annals of internal medicine.